The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
Open accessAbstract
Theophylline has been a mainstay in the treat- ment of asthma for over 50 years.Its thera- peutic value stems from a combination of anti- inflammatory and bronchodilator activities in addition to its ability to increase diaphragmatic contractility.14Although the pharmacological effects of theophylline have been studied extensively both in the laboratory and in the clinic, the molecular mechanisms res- ponsible for its activity in asthma remain ill defined.In fact, several cellular activities probably contribute to its action, including cyclic nucleotide phosphodiesterase inhibi- tion,' 5 adenosine receptor antagonism,6 stimulation of catecholamine release,7 and a poorly understood ability to increase the num- ber and activity of suppressor T lymphocytes.8Of theophylline's many activities, phos- phodiesterase inhibition may be the most important.Hypothetically, at least two therapeutically beneficial effects could result from inhibition of phosphodiesterase activity and the consequent rise in intracellular aden- osine 3',5'-monophosphate (cAMP) or guan- Cyclic AMP osine 3',5'-monophosphate (cGMP) concen- trations in key cells concerned in the pathophysiology of asthma (figure).Firstly, both cAMP and cGMP mediate airway smooth muscle relaxation,9 10 so a rise in either of these second messengers in airway smooth muscle should result in bronchodilatation.Secondly, the ability of PDE inhibitors to increase the cAMP content of inflammatory cells leads to an inhibition of cell activation.5 1112 In principle, then, PDE inhibitors should possess antiinflammatory activity.Although it is useful in the treatment of asthma, the value of theophylline is limited by a narrow therapeutic index and a wide range of gastrointestinal, central nervous system, and cardiovascular side effects.`4These sideeffects are generally ascribed to its lack of selectivity.Of particular importance in this respect is theophylline's ability to antagonise adenosine receptors and inhibit phosphodiesterase activity in inappropriate tissues (for example, gastrointestinal, central nervous sys- tem, cardiovascular).213 The development of drugs that couple the efficacy of theophylline CyclicGMP| Hormone Receptor
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bourne, H. R., Weinstein, Y., Melmon, K. L., Lichtenstein, L. M., Henney, C. S., & Shearer, G. M. (1974) · Science · doi:10.1126/science.184.4132.19 · Cited by 914
Beavo, J. A., & Reifsnyder, D. H. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90066-h · Cited by 849
Relationships between calcium and cyclic nucleotides in cell activation.
Rasmussen, H., & Goodman, D. B. (1977) · Physiological Reviews · doi:10.1152/physrev.1977.57.3.421 · Cited by 848
Zurier, R. B., Weissmann, G., Hoffstein, S. T., Kammerman, S., & Tai, H. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107550 · Cited by 560
Nicholson, C. D., Challiss, R. A. J., & Shahid, M. H. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90484-a · Cited by 457
IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNG
Kaliner, M., Orange, R. P., & Austen, K. F. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.3.556 · Cited by 457
Are Methylxanthine Effects Due to Antagonism of Endogenous Adenosine?
Fredholm, B. B. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90046-4 · Cited by 409
New Positive Inotropic Agents in the Treatment of Congestive Heart Failure
Colucci, W. S., Wright, R. F., & Braunwald, E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601303140506 · Cited by 397
Renz, H., Gong, J. H., Schmidt, A., Nain, M., & Gemsa, D. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2388 · Cited by 394
New Positive Inotropic Agents in the Treatment of Congestive Heart Failure: (Second of Two Parts)
Colucci, W. S., Wright, R. F., & Braunwald, E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602063140605 · Cited by 341
Characterization of Cyclic Nucleotide Phosphodiesterases of Rat Tissues
Thompson, W. J., & Appleman, M. M. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62207-0 · Cited by 302
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta
Lugnier, C., Schoeffter, P., Le Bec, A., Strouthou, E., & Stoclet, J. C. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90333-3 · Cited by 301
Hydrolysis of Cyclic Guanosine and Adenosine 3',5'-Monophosphates by Rat and Bovine Tissues
Beavo, J. A., Hardman, J. G., & Sutherland, E. W. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62703-6 · Cited by 299
Cyclic GMP and mechanisms of vasodilation
Lincoln, T. M. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90127-7 · Cited by 250
Weishaar, R. E., Cain, M. H., & Bristol, J. A. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm50001a001 · Cited by 248
Wachtel, H. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90239-3 · Cited by 240
Human Pulmonary Endothelial Cells in Culture
Johnson, A. R. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109736 · Cited by 229
Isolation and characterization of a mammalian gene encoding a high-affinity cAMP phosphodiesterase.
Colicelli, J., Birchmeier, C., Michaeli, T., O'Neill, K., Riggs, M., & Wigler, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3599 · Cited by 189
Godard, P., Chaintreuil, J., Damon, M., Coupe, M., Flandre, O., de Paulet, A. C., & Michel, F. B. (1982) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(82)90234-2 · Cited by 178
Swinnen, J. V., Joseph, D. R., & Conti, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5325 · Cited by 172
Cyclic AMP and mechanisms of vasolidation
Murray, K. J. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90060-f · Cited by 170
Nielson, C. P., Vestal, R. E., Sturm, R. J., & Heaslip, R. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80186-1 · Cited by 170
Takenawa, T., Ishitoya, J., & Nagai, Y. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36058-1 · Cited by 163
Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase.
Livi, G. P., Kmetz, P., McHale, M. M., Cieslinski, L. B., Sathe, G. M., Taylor, D. P., Davis, R., Torphy, T. J., & Balcarek, J. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.6.2678 · Cited by 128
Self-citationWhite, J. R., Ishizaka, T., Ishizaka, K., & Sha'afi, R. I. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.3978 · Cited by 117
Phosphodiesterase inhibition and theophylline.
Bergstrand, H. (1980) · PubMed · Cited by 103
Cooper, K. D., Kang, K., Chan, S. C., & Hanifin, J. M. (1985) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12272486 · Cited by 102
Is Phosphodiesterase inhibition a new mechanism of antidepressant action?
Bobon, D. P., Breulet, M., Gerard-Vandenhove, M. A., Guiot-Goffioul, F., Plomteux, G. J., Sastre-y-Hernández, M., Schratzer, M., Troisfontaines, B., von Frenckell, R., & Wachtel, H. (1988) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00381071 · Cited by 93
Nielson, C., Crowley, J. J., Morgan, M. E., & Vestal, R. E. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.1.25 · Cited by 89
Nielson, C. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.7.2392 · Cited by 85
Souness, J. E., Brazdil, R., Diocee, B. K., & Jordan, R. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb14599.x · Cited by 81
Macphee, C. H., Harrison, S. A., & Beavo, J. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6660 · Cited by 80
Direct stimulant effect of aminophylline on catecholamine release from the adrenal medulla
Poisner, A. M. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90288-8 · Cited by 70
Sevilla, D. C., Dohrmann, M. L., Somelofski, C. A., Wawrzynski, R. P., Wagner, N. B., & Wagner, G. S. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)91072-2 · Cited by 69
Innervation of Airway Smooth Muscle
Laitinen, L. A., & Laitinen, A. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.4_pt_2.s38 · Cited by 41
Undem, B. J., Torphy, T. J., GOLDMAN, D. W., & Chilton, F. H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39213-0 · Cited by 37
Self-citationBryson, S. E., & Rodger, I. W. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11371.x · Cited by 37
Relationships between adenosine, cyclic nucleotides, and xanthines in asthma
Church, M. K., Featherstone, R. L., Cushley, M. J., Mann, J. S., & Holgate, S. T. (1986) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(86)90044-8 · Cited by 36
Hall, I. P., Donaldson, J., & Hill, S. J. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90013-b · Cited by 33
Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase.
Weiss, B. (1975) · PubMed · Cited by 30
Polson, J. B., Krzanowski, J. J., & Szentivanyi, A. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90301-6 · Cited by 24
Does Theophylline Potentiate Inhaled β2‐Agonists?
Svedmyr, K., & Svedmyr, N. (1982) · Allergy · doi:10.1111/j.1398-9995.1982.tb01883.x · Cited by 20
Cited by
Lugnier, C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 870
Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
Self-citationCyclic nucleotide phosphodiesterases: Relating structure and function
Francis, S. H., Turko, I. V., & Corbin, J. D. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)65001-8 · Cited by 564
Boswell‐Smith, V., Spina, D., & Page, C. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706495 · Cited by 405
Therapeutic Potential of Boron-Containing Compounds
Baker, S. J., Ding, C. Z., Akama, T., Zhang, Y.-K., Hernandez, V., & Xia, Y. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.71 · Cited by 373
Metadata
- Authors
- Torphy, T. J., & Undem, B. J.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 1991-07-01
- Volume
- 46
- Issue
- 7
- Pages
- 512-523
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2164508592
- Cited by
- 380
- References
- 42
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.